Back to Journals » Drug Design, Development and Therapy » Volume 9

Cost-effectiveness analysis of lamivudine, telbivudine, and entecavir in treatment of chronic hepatitis B with adefovir dipivoxil resistance

Total article views   HTML views PDF downloads Totals
8,906 Dovepress* 7,765+ 1,592 9,357
PubMed Central* 1,141 378 1,519
Totals 8,906 1,970 10,876
*Since 2 June 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar